Trial of anticoagulant vs antiplatelet therapy feasible in cancer patients with stroke

January 10, 2018

Trial of anticoagulant vs antiplatelet therapy feasible in cancer patients with stroke

Published on 01/09/2018

previous post: Hot flashes caused by cancer therapy can be prevented, treated
next post: No evidence of increase in calcitonin concentrations or development of C-cell malignancy in response to liraglutide for up to 5 years in the LEADER Trial